1[1]Kitaoka LL, Takata J, Hitomi N, et al. Effect of angiotensin-converting enzyme inhibitor (enalapril or imidapril)on chronic heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol,2000,85(5):658
2[2]Civertz MM, Collucci WS. New targets for heart failure therapy:endothelin, inflammatory, cytokines, oxidative stress. Lancet, 1998,352(suppl 1):34
3[3]Packer M,Cohn JN. On behalf of ACTION-HF:consensus recommendations for the management of chronic heart failure. Am J Cardiol, 1999,83:1
4[4]Masura J,Gavora P, Formanek A, et al. Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder:intial human experience. Cathet Cardiovasc Diagn,1997,42:388
5[5]Yanagawa H, Tuohong Z,Oki I, et al. Effects of gamma-globulin on the cardiac sequelae of kawasaki disease. Pediatr Cardiol, 1999,29(4):248
